There is described herein a drug eluting medical device. In an aspect, thedevicecomprises an implantable intraluminal structure a first polymeric solution adrug intherapeutic dosages, incorporated into the first polymeric solution creating aresultingmixture a separate and distinct antioxidant incorporated into the resultingmixture tosubstantially hinder degradation of the drug through oxidation, therebycreating a basecoat with the antioxidant mixed or comingled with the drug in the base coat,the basecoat being affixed to at least a portion of the implantable intraluminalstructure and asecond polymeric solution forming a top coat affixed to the base coat.
